Glucocorticoids

Three things that are all true

1. They can help fast. Short-term low-dose systemic steroids reduce symptoms compared with placebo or NSAIDs in classic trials.
2. They may also help slow joint damage when added to DMARDs. Evidence from trials shows less progression of damage on X-rays in that setting.
3. Long-term use comes with important risks. Fractures and infections are among those risks.

This is why steroids are often described as a “bridge.” They can provide temporary help while a disease-modifying medicine starts working or while treatment is being changed. The goal is then to taper them rather than let temporary treatment quietly become permanent treatment.

What “bridge” means in ordinary life

A bridge is a planned short course with an exit.

It is not a parking place.

You might hear steroids offered when methotrexate or another DMARD is starting, when therapy is being escalated, or during a bad flare.

Feeling better within days is real.

That relief is not proof that steroids should become your main long-term plan.

What taking part usually involves

• A clear plan for the dose, expected duration, and how the steroid will be reduced or stopped.
• Attention to harms that can increase with longer use, especially fractures and infections.
• A disease-modifying treatment plan alongside the steroid, because steroids aren't meant to do the long-term job alone.
• Honesty about repeated “short” courses. They still add up.

Common confusions

“I feel better, so I’ll stay on prednisone.” Feeling better quickly is exactly why steroids can be useful. It doesn't make long-term use harmless.

“If steroids can slow damage on X-rays, wouldn't taking more for longer work even better?” No. The evidence for radiographic benefit does not erase the harms of prolonged treatment or the goal of tapering.

“Steroids can replace methotrexate or a biologic.” They generally play a different role: temporary help while disease-modifying treatment provides longer-term control.